Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

The cost of illegal immigration is a hot-button issue – and Democrats have a wide range of reactions. In this video, we break down how Democratic leaders and voters are responding to the economic, ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

Ozempic and Wegovy would no longer be covered by the state’s health insurance for low-income people under the governor’s ...

Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing ...

The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.

Stock futures rose on Wednesday on optimism around trade talks with China. Treasury Secretary Scott Bessent and Trade Representative Jamieson Greer are slated to meet with Chinese officials for the ...

U.S. trade policy has also heightened investor concerns over the potential impact to Novo Nordisk's key market. U.S. President Trump has threatened to unveil tariffs on pharmaceutical products in the ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Ozempic Insulin box and injection pen or insulin cartridge pen for diabetes patients from Novo Nordisk. Blurred pharmacy background. Copenhagen, Denmark - January 29, 2024. Ozempic/Wegovy can help ...

Ozempic (semaglutide) is a medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes. Because Ozempic has been shown to boost weight loss in people with diabetes, it ...

Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.